Articles by Eric Langer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Eric Langer
« Previous
1234
Next »

Wanted: Better Upstream Bioprocessing Technologies

A recent industry survey shows keen interest in improving bioreactors and cell-culture media.
Jun 2, 2011
By: Eric Langer

A recent industry survey shows keen interest in improving bioreactors and cell-culture media.

Changes Underway for Biopharmaceutical Outsourcing

More crucial biomanufacturing operations are expected to be outsourced.
Mar 2, 2011
By: Eric Langer

More crucial biomanufacturing operations are expected to be outsourced.

Changes Underway for Biopharmaceutical Outsourcing

More crucial biomanufacturing operations are expected to be outsourced.
Feb 2, 2011
By: Eric Langer

More crucial biomanufacturing operations are expected to be outsourced.

Outsourcing Winners in 2014

Post recession and beyond, which contract service providers will still be standing?
Nov 2, 2010
By: Eric Langer

Post recession and beyond, which contract service providers will still be standing?

Project Managers Wanted

Relationship management is a limiting factor to growth in biomanufacturing outsourcing.
Sep 1, 2010
By: Eric Langer

Relationship management is a limiting factor to growth in biomanufacturing outsourcing.

Project Managers Wanted

Relationship management is a limiting factor to growth in biomanufacturing outsourcing.
Aug 2, 2010
By: Eric Langer

Relationship management is a limiting factor to growth in biomanufacturing outsourcing.

Waste Not, Want Not

Restructuring in the biopharmaceutical industry is renewing a focus on resource optimization.
Jun 9, 2010
By: Eric Langer

Restructuring in the biopharmaceutical industry is renewing a focus on resource optimization.

Waste Not, Want Not

Restructuring in the biopharmaceutical industry is renewing a focus on resource optimization.
Apr 2, 2010
By: Eric Langer

Restructuring in the biopharmaceutical industry is renewing a focus on resource optimization.

A Bio View of Outsourcing

Strategic rather than tactical considerations are driving biopharmaceutical outsourcing.
Mar 3, 2010
By: Eric Langer

Strategic rather than tactical considerations are driving biopharmaceutical outsourcing.

« Previous
1234
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here